Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs.

Publication Year: 2023

DOI:
10.1007/s11136-023-03365-6

PMCID:
PMC9930058

PMID:
36790666

Journal Information

Full Title: Qual Life Res

Abbreviation: Qual Life Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physical and Rehabilitation Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestAuthors declare that they have no competing interests. Ethical approvalThe ethics committee approval of the study was received by Selcuk University Faculty of Health Sciences Non-Interventional Clinical Research Ethics Committee on 29.04.2020 with the decision number 2020/421. However, due to the title change in the process, the relevant ethics committee approval was received again for the new title with the date 27.11.2021 and the decision number 2021/04. In addition, permission was obtained from the Head Physician of Necmettin Erbakan University Meram Medical Faculty Hospital, with the letter dated 05.06.2020 and numbered E.8916, for the study to be conducted in the Medical Oncology Department of Necmettin Erbakan University Meram Medical Faculty Hospital. Informed consentThe participants who agreed to participate in the research were informed about the research, and their written and verbal consent were obtained to participate in the research. Conflict of interest Authors declare that they have no competing interests."

Evidence found in paper:

"Funding This research was carried out 2019-ÖYP-009 project number with the allowance given by the Council of Higher Education within the scope of the Lecturer Training Program (LTP) at Selcuk University LTP Coordinatorship."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025